Glycosylated polypeptide and drug composition containing said polypeptide

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9422357
SERIAL NO

14342359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

[Problem] To provide a glycosylated polypeptide having an affinity to somatostatin receptors, and, compared to somatostatins, having improved in-blood stability. [Solution] The glycosylated polypeptide is characterized by at least one amino acid in a somatostatin or an analog thereof being replaced with a glycosylated amino acid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLYTECH INCKYOTO JAPAN KYOTO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fukae, Kazuhiro Tokushima, JP 27 107
Ishii, Kazuyuki Kyoto, JP 17 70
Maeda, Masatoshi Tokyo, JP 31 534
Ochiai, Hirofumi Kyoto, JP 8 20
Shimoda, Taiji Kyoto, JP 9 17
Tazuru, Keisuke Kyoto, JP 6 17
Tezuka, Katsunari Kyoto, JP 38 721
Yoshida, Kenta Hyogo, JP 26 100

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 23, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00